← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SENORES PHARMS · Approved 2022-03-10

Drug application

FDA Application #

ANDA214346

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

NYSTATIN

Active ingredients

NYSTATIN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

SENORES PHARMS

Manufacturer

Leading Pharma, LLC

First approval

2022-03-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown